Penile erection is completely dependent on commands from the central nervous system. Spinal centers controlling penile erection are located in the thoracolumbar and lumbosacral spinal cord. These centers are activated by information from the periphery and supraspinal nuclei so as to elicit penile erection in a variety of physiological contexts. A small number of nuclei including the locus coeruleus located in the pons sends noradrenergic ®bers to the forebrain and spinal cord, including those areas controlling penile erection. Recent morphological techniques such as in situ hybridization and autoradiography using radioligand binding permit investigation of the brain and spinal pathways utilizing alpha adrenoceptor subtypes. Furthermore, pharmacological experiments suggest a modulatory role for noradrenaline in the control of penile erection either in the brain or in the spinal cord. The most robust evidence is that central inhibition of alpha-2 adrenoceptors facilitates sexual function. Taken together, the data propose new directions in the physiological exploration of penile erection and the therapeutic approach of erectile dysfunction.
Introduction
Erection is a vascular event controlled by neurohumoral regulation. 1 Erection occurs in a variety of contexts, which suggests the presence of different neural mechanisms involved in its onset, maintenance and termination. 2, 3 A variety of peripheral nerves, spinal segments, brainstem, pons and hypothalamic nuclei have been demonstrated that control the delicate balance between contraction, basal tone and relaxation of penile trabecular smooth muscles, and penile arterial smooth muscles. In order to provide a better understanding of the neurobiology of penile erection, it is mandatory to dichotomize between its central and peripheral neural controls. However, the limit of such dichotomy is represented by the spinal cord, that contains autonomic sympathetic and parasympathetic neurons, and that receives and integrates proerectile information from the periphery (represented by sensory information from the genitalia) and from supraspinal nuclei. 4 In turn, supraspinal nuclei (e.g. the paraventricular nucleus and the medial preoptic area of the hypothalamus) may be considered as supraspinal re¯ex centers, because they also receive information from sensory afferents from the genitalia. Recent progress in the neural control of penile erection have pointed out the role of several classical neuromediators (e.g. noradrenaline, neuropeptides) and new neural messengers (e.g. nitric oxide). 1 An intriguing point is evidence for a peripheral and central effect on the control of penile erection for the same neuromediator. Noradrenaline, the well-recognized antierectile agent released in the corpus cavernosum by terminals of the postganglionic sympathetic neurons, acts on alpha-1 adrenoceptors to elicit contraction of penile smooth muscle. A variety of alpha adrenoceptor subtypes have been evidenced in the erectile tissue of humans and animals. 5±8 Noradrenaline also activates sexual motivation and modulates re¯exive erection through central and spinal alpha-1 and alpha-2 adrenoceptors.
There has been considerable progress in the understanding of penile erection. Contributions from basic and clinical research prompted pharmaceutical companies to develop several strategies for pharmacologic treatments aimed at restoring penile erection in patients suffering from erectile dysfunc-tion. It is therefore clinically important to better understand the different mechanisms through which a drug, acting on penile erection, may activate one or several pathways, either local, peripheral or central. The purpose of the present review is to focus on the central noradrenergic pathways that control penile erection.
Anatomy

Spinal nuclei that control penile erection
The lumbosacral spinal cord contains the autonomic and somatic motoneurons that innervate the penis and the perineal striated muscles. Activation of the lumbosacral parasympathetic pathways, issued from the sacral segments of the spinal cord in a variety of mammals including humans, and from the L6-S1 spinal cord in rats, leads to penile erection. 9 Parasympathetic preganglionic neurons, whose axons run in the pelvic nerves, are present in the sacral parasympathetic nucleus, i.e. in rats the intermediolateral cell column of the L6-S1 spinal cord. Additional activity of pudendal motoneurons leads to an increased rigidity of the penis. 10 This is due to the contraction of the striated ischiocavernosus (IC) and bulbospongiosus (BS) muscles on the engorged penis. Both preganglionic parasympathetic neurons and pudendal motoneurons contribute to erection in physiological conditions. 9, 11 The contribution of the sympathetic out¯ow has also been recently examined. In rats preganglionic sympathetic neurons are present in the intermediolateral cell column of the T13-L2 spinal cord. 9 Sympathetic ®bers destined to the penis run in the hypogastric nerves and the paravertebral sympathetic chain. Distally, postganglionic ®bers run in the cavernous and the pudendal nerves. The sympathetic innervation is responsible, in part, for the tonic contraction of penile smooth muscle during the¯accid state. 1, 12 The sympathetic nervous system, because it is critically involved in the regulation of blood pressure and vasomotor tone, also indirectly regulates penile erection through the control of the blood vessels and penile vasculature. This has recently been con®rmed in a rat model of centrally induced erection. 13 Preganglionic sympathetic and parasympathetic neurons and motoneurons are unlikely to be excited directly by sensory afferents from the gentialia. Rather, spinal interneurons are present in proerectile re¯ex loops. The same or other interneurons also receive information from supraspinal nuclei. In rats, recent tract tracing techniques, using transsynaptic retrograde labelling with pseudorabies virus injected in the corpus cavernosum or the IC and BS muscles, have identi®ed these populations of interneurons. They are present in the dorsal grey commissure of the L6±S1 spinal cord, in the area around the central canal and the intermediate grey matter of the thoracolumbar and lumbosacral spinal cord. 14, 15 Neurons in the same areas express the immediate early gene fos in response to stimulation of the dorsal penile nerve. 16 
Central noradrenergic pathways
Central noradrenergic pathways contribute to the regulation of locomotor activity, alertness and effect. They also densely innervate the spinal cord, suggesting an important role of the noradrenergic system in the control of re¯ex responses and of the autonomic and somatic out¯ows. 17 The pontine A5, A6 (locus ceruleus) and A7 nuclei contain the cell bodies of noradrenergic neurons (see ref. 18 for review). These nuclei were transneuronally labeled from the penis and the striated muscles.
14, 15 The ®rst evidence for the presence of noradrenergic ®bers in the spinal cord has been provided using the Falck-Hillarp¯uorescence histochemistry. 19, 20 Origin and distribution of spinal noradrenergic ®bers have been further evidenced by using either dopamine-beta-hydroxylase (DBH) immunohistochemistry or retrograde transport of DBH antibody, the latter being selectively taken up by adrenergic and noradrenergic systems. DBH is the key enzyme of noradrenaline and adrenaline synthesis. DBH-IR (immunoreactive) ®bers have been found in the rat spinal cord in the sympathetic preganglionic nuclei at the thoracic and lumbar levels, in the sacral parasympathetic nucleus and around pudendal motoneurons. 17, 21, 22 By using an antibody raised against noradrenaline, a wide distribution of noradrenergic ®bers at all spinal levels has been described. 23 However, direct evidence of relationships between catecholaminergic ®bers and spinal neurons destined to the pelvic organs is lacking.
Adrenergic receptors
A variety of adrenoceptors have been demonstrated in the brain and spinal cord of humans and animals ( Tables 1, 2 and 3) . 24±27 The presence of alpha and beta-adrenoceptor subtypes in the spinal cord of male rats has been demonstrated. 28±31 In situhybridization studies have revealed the presence of mRNAs encoding for alpha-1a, b and d adrenoceptor subtypes in neurons of the rat lumbosacral spinal cord. 32 The distribution of the alpha-2 adrenoceptor subtypes in the male rat has also been shown by using subtype-speci®c antibodies. Alpha-2A and alpha-2C adrenergic receptor immunoreactive ®bers (AR-IR) were observed in the super®cial layers of the dorsal horn at all spinal levels, around the central canal and in the intermediolateral cell column of the Central noradrenergic control of penile erection F Giuliano and O Rampin thoracic spinal cord. 33±35 In humans, demonstration of alpha-2a, alpha-2b, and alpha-2c adrenoceptor subtype mRNAs in the autonomic nuclei of the thoracolumbar and sacral spinal cord has been performed. 24 Therefore, noradrenaline released by DBH-immunoreactive neurons could exert a variety of effects through interaction with different spinal adrenoceptors. The distribution of receptors, in those spinal areas that contain DBH-immunoreactive ®bers, suggests that noradrenaline regulates autonomic and somatic out¯ows. This regulation may be either direct, or through the control of interneurons, e.g., in the dorsal grey commissure that, in turn, project onto them. Preliminary results from our group demonstrate the presence of alpha2a and alpha-2c adrenoceptor subtypes in the thoracolumbar and lumbosacral segments of the rat spinal cord. Using transsynaptic axonal transport from the corpus cavernosum, we found that sympathetic and parasympathetic preganglionic neurons innervating the penis are in close apposition with neural terminations immunoreactive for alpha-2a and alpha-2c adrenoceptor subtypes ( Figure 1A ). There remains to be determined the speci®c effects of noradrenergic descending projections onto thoracolumbar sympathetic, lumbosacral parasympathetic and pudendal motoneurons that control penile erection. A shift in this control might contribute to the temporal evolution of erection to ejaculation. However, the integration of such descending in¯uences by the intraspinal circuitry remains to be elucidated.
Spinal circuits controlling penile erection and their noradrenergic innervation
We recently provided evidence of synaptic contacts between DBH-IR ®bers and both sympathetic and parasympathetic pelvic preganglionic neurons and Table 1 Relative distribution of mRNA for alpha-1a, alpha-1b and alpha-1d adrenoceptor subtypes in the rat brain nuclei whose role in the central control of penile erection has been demonstrated or hypothesized
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32 Table 2 Relative distribution of alpha-1 adrenoceptor subtypes in the rat spinal cord
32 (Figures 1B, 2A) . 36 In male rats, such appositions have been inferred from the occurrence of DBH immunoreactivity in ®ber pro®les in the autonomic areas of the spinal cord, as well as in motoneuronal areas. Synaptic contacts have also been demonstrated between DBH-IR or noradrenergic immunoreactive ®bers and motoneurons in the L5±S1 spinal cord of male rats and in the S2±S3 spinal cord of male monkeys (see above). The L5±L6 spinal cord in rats and Onuf's nucleus in monkeys (in the L5±S1 spinal cord) contain a variety of pudendal motoneurons that innervate different perineal striated muscles and sphincters. 37, 38 In rats, the dorsomedial (DM) nucleus contains motoneurons innervating the BS muscle. Those motoneurons are intermingled with others destined to the external anal sphincter. By using retrograde axonal transport combined with DBH-immunohistochemistry, we demonstrated that there exist a speci®c DBH positive innervation of the motoneurons innervating the IC and BS muscles. We further identi®ed synapses between DBH ®bers and dendrites and somata of retrogradely labeled neurons as demonstrated by electron microscopy ( Figure 2B) . 36 In the Central noradrenergic control of penile erection F Giuliano and O Rampin SPN, we documented small clear vesicles in DBH-IR terminals, suggesting that another neuromediator could be colocalized with noradrenaline. Therefore a direct noradrenergic innervation of autonomic preganglionic neurons destined to the pelvic organs and of motoneurons innervating the IC and BS muscles was identi®ed.
Pharmacology
Sexual function and penile erection models
As already reported, penile erection occurs in a variety of contexts: during copulation, during sleep and in response to local stimulation or sexual fantasy. 1, 2 In animal models, penile erection has been either inferred from behavioral observations of the animals (e.g. during copulation in rats), documented through direct observation of the penis (e.g. during re¯exive erections in rats) or measured through intracavernous pressure in anesthetized or conscious animals (in rats, see ref. 39 ). Drugs interacting with noradrenergic transmission have been tested on these models. However, a major dif®culty arising from these studies and their interpretation is whether the compounds acted either at the periphery or in the brain. In a few studies, drugs were delivered directly in brain nuclei or intrathecally. We report here on these experiments. During copulation, male rats in the presence of a receptive female perform a series of mounts accompanied or not by an intromission leading to ejaculation. Each mount or intromission is accompanied by an erection, and each mount or intromission lasts 1±2 s. Each mount, intromission and ejaculation is accompanied by pelvic thrusting. Adult male, sexually trained, rats perform 7±10 intromissions before an ejaculation, the latter appearing at a latency of 10 min. Ejaculation is followed by a refractory period, then the male resumes copulation. Latency to ®rst mount and the number of mounts are considered excellent measures of sexual motivation. Intromissions, latency to ejaculation, duration of the refractory period and the number of ejaculations are measures of sexual performance. During re¯exive erections, male rats are restrained on their back, and tonic retraction of the preputial sheath elicits bursts of penile erections. 40, 41 The generator of re¯exive erections is located within the spinal cord. 40, 42 Evidence for noradrenergic control of sexual functions: general effects Noradrenaline has been shown to modulate copulation and sexual re¯exes. The alpha-1 adrenoceptor antagonist prazosin and the alpha-2 adrenoceptor agonist clonidine both depressed copulation in male rats. 43 In adult male Long-Evans rats, yohimbine, an alpha-2 adrenergic receptor antagonist, increased sexual motivation, as evidenced by increased mounting performance, increased percentage of male rats ejaculating in their ®rst heterosexual encounter, and increased induction of copulation in sexually inactive males. 44 Yohimbine administered 25 min before copulation tests restored sexual activity in sexually exhausted male rats. 45 Lesioning the locus ceruleus, the main source of the noradrenergic innervation of the spinal cord, produced a signi®cant increase in the duration of the postejaculatory refractory period. This effect was mimicked by the administration of norepinephrine synthesis inhibitors 46 and also caused an increase in both mount and intromission latencies. Bilateral lesions of the locus ceruleus elicited priapism in 3a6 rats. 47 
Spinal pharmacology
In copulating male rats, intrathecal infusion of noradrenaline was shown to accelerate pelvic thrusting, suggesting a facilitatory effect of noradrenaline on the activity of motoneurons destined to the lower limbs, hips or perineum. 48 In ex copula penile re¯ex tests, clonidine, an alpha-2 adrenergic receptor agoinst, delivered at the periphery decreased the number of penile responses. 49 Yohimbine also delivered peripherally displayed biphasic effects on re¯exive erections. When delivered intraperitoneally immediately before the test, yohimbine exerted a dose-dependent effect on the number of re¯exive erections. Low doses of yohimbine slightly increased re¯exive erections and high doses decreased it. 50 Rats acutely treated with guanethidine, an adrenergic neuron blocking agent, displayed an increased number of¯ips during penile re¯ex tests. 51 The presence of DBH-IR ®bers in the lumbosacral spinal cord suggests that noradrenaline may modulate autonomic and somatic out¯ows destined to the urogenital tract, including the penis, in male rats. In keeping with this hypothesis is the inhibition of the re¯exive urethral constriction in cats (males and females) by prazosin; an alpha-1 adrenergic receptor antagonist and clonidine. 52, 53 Alpha-1 adrenergic receptors facilitated the re¯ex response of the pudendal and hypogastric nerves in response to stimulation of the pudendal and pelvic nerves, respectively, in anesthetized cats. 54, 55 Finally, electrophysiological studies using iontophoretically delivered noradrenaline or related compounds in the vicinity of spinal neurons demonstrated that the activity of thoracic sympathetic preganglionic neurons was activated by alpha-1 and depressed by alpha-2 adrenoceptor agonists. 56 In contrast, nor-adrenaline activated sacral parasympathetic interneurons through alpha-1 adrenoceptors. 57 
Brain pharmacology
Central effects of clonidine were further demonstrated in an experiment where administration of the drug either intracerebroventricularly or in the medial preoptic area of the hypothalamus suppressed copulatory behavior. 58 
Conclusions
There exist both morphological and pharmacological evidence to support a role for noradrenaline in the neural control of penile erection both at the brain and spinal cord level. Nevertheless, the alpha adrenoceptor subtypes mediating this regulation remain uncharacterized. The general view is that central activation of alpha-1 adrenoceptors and inhibition of alpha-2 adrenoceptors facilitates sexual function. However, interpretation of the experimental ®ndings is dif®cult due to lack of knowledge of the peripheral, spinal or central targets of the adrenergic drugs. We propose that the brain and the spinal cord represent major targets for future developments in the physiology and pathophysiology of the neural control of penile erection by adrenergic systems. Accordingly, drugs targeting the central noradrenergic control of penile erection undoubtedly represent a promising therapeutical approach for the treatment of erectile dysfunction. Penile erection re¯ects an adaptation of the local vascular system. During sexual behavior, penile erection occurs concurrently with a broader adaptation of the cardiovascular system. It is noteworthy that control of both cardiovacular system and penile erection recruits centrally and peripherally a variety of adrenoceptor subtypes. Furthermore, the central neural control of these two functions share the same nuclei in the hypothalamus, pons and medulla. Accordingly, it is tempting to postulate that the understanding of the neural control of both systems will be enriched by the cooperation and collaboration between clinicians and scientists interested in cardiovascular regulation and penile eretion. 
